Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977432 | 0.86 | IKBKB (0.41) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL15977524 | 0.84 | IKBKB (0.40) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL890113 | 0.84 | CYP1A2 (0.52) | CYP1A2ALDH1A1CYP3A4CYP2C9HPGD | |
| SCHEMBL12359230 | 0.82 | CYP11B2 (0.59) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL10147747 | 0.82 | FTO (0.41) | CYP11B1CYP11B2CYP17A1CYP19A1ALDH1A1 | |
| SCHEMBL25763711 | 0.81 | CYP11B1 (0.49) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL3648882 | 0.80 | CYP11B1 (0.52) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL27785002 | 0.79 | CYP11B1 (0.47) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL15977556 | 0.79 | PSMB5 (0.40) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 | |
| SCHEMBL17899315 | 0.78 | CYP11B1 (0.53) | CYP11B1CYP11B2CYP17A1CYP19A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363260-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-11730053-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-15 | — | — | US | disclosed |
| US-11217758-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-04 | — | — | US | disclosed |
| US-10826000-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-11-03 | — | — | US | disclosed |
| US-20200321538-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
| US-10727418-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-28 | — | — | US | disclosed |
| US-10305041-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-28 | — | — | US | disclosed |
| US-20190036043-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-31 | — | — | US | disclosed |
| US-10026906-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-9972789-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-15 | — | — | US | disclosed |
| US-9887364-B2 | Organic light-emitting devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-9818950-B2 | Organic light-emitting devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9666807-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-05-30 | — | — | US | disclosed |
| US-20160111664-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| US-20160111664-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| US-20160028017-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-01-28 | — | — | US | disclosed |
| US-20150171337-A1 | AMINE-BASED COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-18 | — | — | US | disclosed |
| US-8163756-B2 | For example,1-(3-t-butyl-1- (1,2,3,4-tetrahydro- isoquinolin-6-yl)-1H- pyrazol-5-yl)-3-(3- cyanophenyl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies | DECIPHERA PHARMACEUTICALS, LLC (US) | 2012-04-24 | — | — | US | disclosed |
| US-20080113967-A1 | ENZYME MODULATORS AND TREATMENTS | DECIPHERA PHARMACEUTICALS, LLC (US) | 2008-05-15 | — | — | US | disclosed |
| US-20070078121-A1 | Enzyme modulators and treatments | DECIPHERA PHARMACEUTICALS, LLC | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10026906-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNL2, CRY2 | CYP11B1 758/4885CYP11B2 751/4885CYP17A1 1063/4885 |
| US-20070078121-A1 | Enzyme modulators and treatments | ABL1, ABL2, LCK | CYP11B1 2941/4885CYP11B2 3164/4885CYP17A1 2241/4885 |
| US-20080113967-A1 | ENZYME MODULATORS AND TREATMENTS | ABL2, BRAF, MAP3K1 | CYP11B1 2934/4885CYP11B2 3086/4885CYP17A1 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.